Oct 28, 6:01 AM ET
TTM Technologies completed its prior $100 million share repurchase program, which was announced May 8, 2025, and its board authorized a new program of up to $100 million in repurchases running through October 27, 2027. The company says the buybacks were made with cash on hand and that the new program may be suspended or discontinued at its discretion.
- Completed 2025 program: about 1.16 million shares repurchased on October 26 and 27, 2026, at an average price of $86.31 per share, for about $100 million in aggregate
- New 2026 program authorizes repurchases of up to $100 million through October 27, 2027
- Repurchases may be made through open market purchases, privately negotiated transactions or Rule 10b5-1 plans; the company is not obligated to buy any specific amount
Read the filing on SEC.gov ↗
Oct 22, 6:03 AM ET
TTM Technologies reported third quarter 2026 net sales of $1.2 billion, up 60% from a year earlier, with GAAP net income of $84.8 million, or $0.79 per diluted share, versus $53.1 million, or $0.50, in the prior-year quarter. The company guided fourth quarter 2026 net sales to $1.42 billion to $1.44 billion and non-GAAP EPS to $1.77 to $1.83, and gave a preliminary 2027 forecast of $6.5 billion to $6.75 billion in net sales, which shareholders can compare against future results.
- Q3 2026 net sales of $1.2 billion, up from $752.7 million; GAAP net income of $84.8 million, or $0.79 per diluted share, versus $53.1 million, or $0.50, a year earlier
- Non-GAAP net income of $157.8 million, or $1.46 per diluted share, versus $0.67 a year earlier; adjusted EBITDA of $242.3 million, or 20.1% of net sales
- Q4 2026 guidance: net sales of $1.42 billion to $1.44 billion and non-GAAP EPS of $1.77 to $1.83 per diluted share
- Preliminary 2027 forecast: net sales of $6.5 billion to $6.75 billion and non-GAAP EPS of $8.10 to $8.90; the proposed $650 million Ophir Optics acquisition is not included in guidance
Read the filing on SEC.gov ↗
Oct 19, 8:16 AM ET
TTM Technologies agreed to acquire the Ophir Optics business from MKS Inc. for approximately $650 million in an all-cash deal, subject to customary closing adjustments. The company expects the deal to close in the second quarter of 2027, subject to regulatory approvals, and expects it to be immediately accretive to its Adjusted EBITDA Margin and Non-GAAP Diluted EPS.
- Purchase price is approximately $650 million, all cash, with funding from cash on hand, future cash flow and its existing revolving credit facility.
- The transaction multiple is estimated at roughly 10.3x expected FY 2027 Adjusted EBITDA of Ophir Optics, without synergies.
- Expected close is the second quarter of 2027, subject to regulatory approvals and governmental consents and permits.
- Excludes MKS's Ophir Instruments laser characterization business and the Ophir brand.
Read the filing on SEC.gov ↗
Sep 30, 4:33 PM ET
TTM Technologies completed its acquisition of Epiq Solutions on September 30, 2026, paying approximately $1.1 billion in cash, subject to customary adjustments. The purchase was funded with new term loans under a Third Amended and Restated Credit Agreement and proceeds from the company's 6.750% senior notes due 2034. The company expects the deal to be immediately accretive to adjusted EBITDA, moderately dilutive to non-GAAP diluted EPS in 2027, and accretive to non-GAAP diluted EPS in 2028.
- Purchase price of approximately $1.1 billion in cash, paid to the seller on September 30, 2026, subject to working capital and other adjustments
- New incremental facilities of $300 million term loan A and $800 million seven-year term loan B, with JPMorgan Chase Bank, N.A. as administrative agent
- Company expects immediate accretion to adjusted EBITDA, moderate dilution to non-GAAP diluted EPS in 2027, and accretion in 2028
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.